Target intelligence / Profile preview

Activating transcription factor 6 (ATF6)

Target
ATF6
Molecular classification
Transcription factor, Basic leucine zipper (bZIP) protein, Type II ER transmembrane protein, Stress response sensor
01

Overview

Activating transcription factor 6 (ATF6) is a type II transmembrane protein located in the endoplasmic reticulum. It is one of the three primary ER stress sensors and regulators of the unfolded protein response (UPR), alongside PERK and IRE1. ATF6 exists as two main isoforms, ATF6α and ATF6β, which differ in transcriptional activation potency and stability. Under normal conditions, ATF6 is retained in the ER by interaction with the chaperone GRP78/BiP. Upon accumulation of unfolded proteins (cellular stress), GRP78 dissociates, allowing ATF6 to be transported to the Golgi apparatus, where it is proteolytically cleaved by site-1 and site-2 proteases. The cleaved cytosolic fragment translocates to the nucleus, triggering transcription of genes involved in protein folding (chaperones), ERAD, and cell survival. Prolonged or severe ER stress can shift ATF6 downstream signaling from protective to pro-apoptotic.\n\nDisease relevance is pronounced in conditions characterized by aberrant proteostasis, misfolded protein accumulation, and chronic cellular stress. Experimental modulators of ATF6 are under investigation for metabolic, degenerative, inflammatory, and fibrotic diseases. The lack of high-resolution crystal structure for ATF6 presents ongoing challenges for rational drug design.

Other names
ATF6αATF6βUnfolded protein response (UPR) factorER stress transducer
02

Mechanism of action

Modulating ATF6 activation and nuclear translocation to either enhance protective UPR/adaptive chaperone expression or suppress pathological prolonged ER stress signaling leading to apoptosis. Small molecules may block or enhance ATF6 cleavage, nuclear import, or DNA binding.

03

Biological functions

Regulation of unfolded protein response (UPR)Protein folding and ER chaperone inductionER-associated degradation (ERAD)Promoting cell survival under ER stressCell death/apoptosis under persistent stressCellular redox regulation
04

Disease associations

Cancer (through proteostasis and cell survival modulation)Inflammation and autoimmune diseaseCongenital retinal diseaseLiver fibrosisMetabolic disease (including diabetes)Other conditions involving protein misfolding or ER stress
05

Safety considerations

Potential for maladaptive UPR: Chronic activation of ATF6 may exacerbate cell death pathways rather than promote adaptation, contributing to tissue pathology (e.g., fibrosis, degenerative disease)Off-target effects: Therapeutic agents targeting ATF6 may affect other bZIP transcription factors or ER stress response elements, with a risk of broad modulation of cell survival and apoptosis pathwaysLack of structural knowledge: Limited information on ATF6 structure impedes specific drug design and has caused concern for potential unforeseen interactions
06

Interacting drugs

Preclinical small molecule modulators (direct)

3 more in the full profile.

07

Biomarkers

BiP/GRP78CHOPDownstream UPR target genes

Beyond the preview

Go deeper on Activating transcription factor 6 (ATF6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activating transcription factor 6 (ATF6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call